## Abstract ## Objectives We evaluated the efficacy and safety of long‐acting risperidone for 48‐week period in Korean patients. ## Methods This was a non‐randomized, open‐label, single‐centered, 48‐week study. Each of the participants visited the hospital every 2 weeks, and injections were give
Pharmacological long-term treatment strategies in first episode schizophrenia
✍ Scribed by Wolfgang Gaebel; Hans-Jürgen Möller; Gerd Buchkremer; Christian Ohmann; Mathias Riesbeck; Wolfgang Wölwer; Martina Wilmsdorff; Ronald Bottlender; Stefan Klingberg
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 312 KB
- Volume
- 254
- Category
- Article
- ISSN
- 1433-8491
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We present the long‐term outcome of 144 musicians with focal dystonia after treatment with botulinum toxin (n = 71), trihexiphenidyl (n = 69), pedagogical retraining (n = 24), ergonomic changes (n = 51), or nonspecific exercises on the instrument (n = 78). Outcome was assessed by patien
Diffuse coronary lesions (length > 20 mm) are still considered high risk for percutaneous intervention even in the current stent era. We compared the 2-year outcome of patients with long diffuse stenosis treated by three different stent strategies. In addition, we also analyzed the possible factors
This analysis of data from the open-label extension (OLE) phases of three randomized clinical trials of quetiapine in patients with schizophrenia (n=415) was undertaken to investigate whether the initial improvements in anxiety and depressive symptoms were maintained during long-term treatment. The